1. Home
  2. CERO vs EVTV Comparison

CERO vs EVTV Comparison

Compare CERO & EVTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • EVTV
  • Stock Information
  • Founded
  • CERO 2017
  • EVTV 2012
  • Country
  • CERO United States
  • EVTV United States
  • Employees
  • CERO N/A
  • EVTV N/A
  • Industry
  • CERO
  • EVTV Auto Manufacturing
  • Sector
  • CERO
  • EVTV Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • EVTV Nasdaq
  • Market Cap
  • CERO 3.5M
  • EVTV 5.1M
  • IPO Year
  • CERO N/A
  • EVTV 2017
  • Fundamental
  • Price
  • CERO $9.40
  • EVTV $0.18
  • Analyst Decision
  • CERO Strong Buy
  • EVTV
  • Analyst Count
  • CERO 2
  • EVTV 0
  • Target Price
  • CERO $45.00
  • EVTV N/A
  • AVG Volume (30 Days)
  • CERO 3.3M
  • EVTV 1.7M
  • Earning Date
  • CERO 08-13-2025
  • EVTV 08-13-2025
  • Dividend Yield
  • CERO N/A
  • EVTV N/A
  • EPS Growth
  • CERO N/A
  • EVTV N/A
  • EPS
  • CERO N/A
  • EVTV N/A
  • Revenue
  • CERO N/A
  • EVTV $1,650,137.00
  • Revenue This Year
  • CERO N/A
  • EVTV N/A
  • Revenue Next Year
  • CERO N/A
  • EVTV N/A
  • P/E Ratio
  • CERO N/A
  • EVTV N/A
  • Revenue Growth
  • CERO N/A
  • EVTV N/A
  • 52 Week Low
  • CERO $6.71
  • EVTV $0.15
  • 52 Week High
  • CERO $895.40
  • EVTV $2.61
  • Technical
  • Relative Strength Index (RSI)
  • CERO 47.17
  • EVTV 43.36
  • Support Level
  • CERO $9.10
  • EVTV $0.16
  • Resistance Level
  • CERO $9.73
  • EVTV $0.20
  • Average True Range (ATR)
  • CERO 2.73
  • EVTV 0.02
  • MACD
  • CERO 0.08
  • EVTV 0.00
  • Stochastic Oscillator
  • CERO 12.57
  • EVTV 46.67

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

Share on Social Networks: